On Thursday the 7th of November TASK Founder and CEO Andreas Diacon was interviewed on South African national television about the recent trial results pertaining to a potential new TB vaccine:

More info can be found here:

https://www.nytimes.com/2019/10/29/health/tuberculosis-vaccine.html?fbclid=IwAR17ErMVbRDYb83Vn_il47bGBjUAgGNm6SMp5oTEHYLIJLXcOtIFgVnA2JE

https://task.org.za/2019/10/30/gsk-candidate-vaccine-demonstrates-sustained-level-of-protection-against-active-pulmonary-tuberculosis/